Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane- 1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 308-314

  Ebenhan, Thomas ^a,b,c   Zeevaart, Jan Rijn ^d   Venter, Jacobus D ^e   Govender, Thavendran ^b   Kruger, Gert H ^b   Jarvis, Neil V ^c   Sathekge, Mike M ^a  

^a STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NECSA   (South Africa)

^d NORTH WEST UNIVERSITY   (South Africa)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Infection; PET CT imaging; UBI29 41; Ubiquicidin

Indexed keywords

GALLIUM 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID UBIQUICIDIN 29 41 GA 68; RADIOLIGAND; UNCLASSIFIED DRUG; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; ANTIMICROBIAL CATIONIC PEPTIDE; DIAGNOSTIC AGENT; GALLIUM; HETEROCYCLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; RIBOSOMAL PROTEIN S30; RIBOSOME PROTEIN; TURPENTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TISSUE LEVEL; DRUG UPTAKE; DRUG URINE LEVEL; ISOTOPE LABELING; MYOSITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS INFECTION; 68GA LABELING; ANIMAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; INFECTION; INFLAMMATION; LUNG; METABOLISM; METHODOLOGY; PET/CT IMAGING; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; UBI29-41; UBIQUICIDIN;

68GA LABELING; INFECTION; PET/CT IMAGING; UBI29-41; UBIQUICIDIN;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; INFECTION; INFLAMMATION; LUNG; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; RIBOSOMAL PROTEINS; STAPHYLOCOCCAL INFECTIONS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TURPENTINE;

EID: 84897950253     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.128397     Document Type: Article

References (35)

1. Palestro CJ. Radionuclide imaging of infection: in search of the grail. J Nucl Med. 2009;50: 671-673.
2. 68Ga-labeled peptides in PET imaging of infection. Nucl Med Commun. 2008;29: 663-665.
3. Tossi A, Sandri L, Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers. 2000;55: 4-30.
4. Knight LC. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med. 2003;47: 279-291.
5. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. J Nucl Med. 2010;51: 1932-1936.
6. 68Ga-citrate-PET for diagnostic imaging of infection in rats and for intra-Abdominal infection in a patient. Curr Radiopharm. 2012;5: 71-75.
7. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med. 2010;51: 639-645.
8. 68Ga-Apo-Transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nucl Med Biol. 2011;38: 393-398.
9. 68Ga-labelled peptides into routine clinical use? Nucl Med Commun. 2011;32: 1109-1112.
10. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415: 389-395.
11. Hiemstra PS, van den Barselaar MT, Roest M, Nibbering PH, van Furth R. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol. 1999;66: 423-428.
12. Hancock RE, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord. 2002;2: 79-83.
13. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000; 27: 292-301.
14. Guérin B, Ait-Mohand S, Tremblay MC, Dumulon-Perreault V, Fournier P, Benard F. Total solid-phase synthesis of NOTA-functionalized peptides for PET imaging. Org Lett. 2010;12: 280-283.
15. 99mTc-UBI specificity for bacteria. Nucl Med Biol. 2003;30: 597-603.
16. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45: 321-326.
17. 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46: 567-573.
18. 99mTc-UBI 29-41 in humans. Nucl Med Biol. 2004;31: 373-379.
19. 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun. 2010;31: 889-895.
20. 99mTc- ubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study. Nucl Med Commun. 2011;32: 745-751.
21. 68Ga generator. Appl Radiat Isot. 2012;70: 171-175.
22. 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol. 2002;29: 413-422.
23. 99mTc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging. 2008;35: 1056-1064.
24. Meléndez-Alafort L, Ramirez Fde M, Ferro-Flores G, Arteaga de Murphy C, Pedraza-Lopez M, Hnatowich DJ. Lys and Arg in UBI: a specific site for a stable Tc-99m complex? Nucl Med Biol. 2003;30: 605-615.
25. De León-Rodríguez LM, Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconjug Chem. 2008;19: 391-402.
26. Moore DAF, Fanwick PE, Welch MJ. A novel hexachelating amino-Thiol ligand and its complex with gallium(III). Inorg Chem. 1990;29: 672-676.
27. 68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot. 2011;69: 308-315.
28. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection. J Nucl Med. 2004;45: 849-856.
29. 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41. Nucl Med Biol. 2004;31: 503-509.
30. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55: 27-55.
31. Lupetti A, Nibbering PH,Welling MM, Pauwels EK. Radiopharmaceuticals: new antimicrobial agents. Trends Biotechnol. 2003;21: 70-73.
32. Bayat S, Strengell S, Porra L, et al. Methacholine and ovalbumin challenges assessed by forced oscillations and synchrotron lung imaging. Am J Respir Crit Care Med. 2009;180: 296-303.
33. Chen DL, Schuster DP. Imaging pulmonary inflammation with positron emission tomography: a biomarker for drug development. Mol Pharm. 2006;3: 488-495.
34. Tigani B, Cannet C, Karmouty-Quintana H, et al. Lung inflammation and vascular remodeling after repeated allergen challenge detected noninvasively by MRI. Am J Physiol Lung Cell Mol Physiol. 2007;292: L644-L653.
35. Korideck H, Peterson JD. Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma. J Pharmacol Exp Ther. 2009;329: 882-889.